Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Other Pharmaceutical Products — Worldwide sales by Year
Other Pharmaceutical Products — Worldwide sales ($M) ($M)
Merck Other Pharmaceutical Products — Worldwide sales: $3,340M in FY2025, up 29.0% from a year earlier.
Where the FY2025 figure comes from
“|| Other Pharmaceutical (7) | 774 | 641 | 1,416 | 865 | 703 | 1,568 | 1,004 | 770 | 3,340 | -9 | -9 | -10 | -11”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Segment & Product Sales Footnote & Form 8-K Table 3 / 3a / 3b.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Pharmaceutical Products — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,340 | +29.0% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 2,590 | +11.0% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 2,333 | +0.6% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 2,319 | +9.5% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 2,118 | -8.4% | Form 8-K (tm2227726d1_ex99-1.htm, filed 2022-10-27) ↗ |
| FY2020 | Dec 31, 2020 | 2,312 | -49.9% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2019 | Dec 31, 2019 | 4,615 | -1.9% | Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | 4,705 | +15.7% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | 4,065 | -11.1% | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2016 | Dec 31, 2016 | 4,574 | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Breakdown
What makes up other Pharmaceutical Products — Worldwide sales
- Other Pharmaceutical Products — U.S. sales ($M)676 · FY2025
- Other Pharmaceutical Products — International sales ($M)2,244 · FY2025
- Other Pharmaceutical Products — Worldwide reported growth YoY (%)13.0% · FY2025
- Other Pharmaceutical Products — Worldwide constant-currency (ex-exchange) growth YoY (%)13.0% · FY2025
- Upfront & milestone payments received for out-licensed products — Worldwide ($M)138 · FY2025
Cite this data
StockData. (2026). Merck Other Pharmaceutical Products — Worldwide sales ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-other-pharma
See every metric in the Merck KPI table. Data updated Oct 26, 2026.